Prostate Cancer Testing is Changing

Rapid advances in precision oncology and new treatment for prostate cancer are challenging pathologists to keep up. Protean provides a complete solution to assist community-based pathologists provide the new testing their patients and oncologists need.

OUR SOLUTION

Protean BioDiagnostics has developed Protean MAPS™ for Prostate Cancer.

Protean MAPS™ for prostate cancer is a comprehensive testing system that evaluates MSI and PDL1 when indicated in prostate cancer specimens. In addition Protean BioDiagnostics will also provide access to multi-gene tumor NGS mutation analysis.

Protean BioDiagnostics views quality as its top priority and holds full CAP CLIA licensure, using only the best in class testing assays and products.